| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:51 UTC |
|---|
| Update Date | 2023-02-21 17:18:28 UTC |
|---|
| HMDB ID | HMDB0015301 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Guanethidine |
|---|
| Description | Guanethidine, also known as octadine or ismelin, belongs to the class of organic compounds known as guanidines. Guanidines are compounds containing a guanidine moiety, with the general structure (R1R2N)(R3R4N)C=N-R5. Guanethidine is a drug which is used for the treatment of moderate and severe hypertension, either alone or as an adjunct, and for the treatment of renal hypertension. Side effects include postural and exercise hypotension, sexual dysfunction (delayed or retrograde ejaculation), and diarrhea.Guanethidine is transported by uptake 1 into the presynaptic terminal transported by norepinephrine transporter (NET). Guanethidine is a very strong basic compound (based on its pKa). Guanethidine is transported across the sympathetic nerve membrane by the same mechanism that transports norepinephrine itself (NET, uptake 1), and uptake is essential for the drug's action. Spontaneous release is not affected.Guanethidine was once a mainstay for hypertension resistant to other agents, and was often used safely during pregnancy, but it is no longer used in the US due to lack of availability. Once inside the terminal it blocks the release of norepinephrine in response to arrival of an action potential. It becomes concentrated in norepinephrine transmitter vesicles, replacing norepinephrine in these vesicles. It is still licensed in some countries, e.g., UK, for the rapid control of blood pressure in a hypertensive emergency. It may also inhibit the release of granules by decreasing norepinephrine. Intravenous nerve block (Bier block) using guanethidine has been used to treat chronic pain caused by complex regional pain syndrome. Once guanethidine has entered the nerve, it is concentrated in transmitter vesicles, where it replaces norepinephrine. This leads to a gradual depletion of norepinephrine stores in the nerve endings. Guanethidine is an antihypertensive drug that reduces the release of catecholamines, such as norepinephrine. |
|---|
| Structure | InChI=1S/C10H22N4/c11-10(12)13-6-9-14-7-4-2-1-3-5-8-14/h1-9H2,(H4,11,12,13) |
|---|
| Synonyms | | Value | Source |
|---|
| (2-(Octahydro-1-azocinyl)ethyl)guanidine | ChEBI | | 2-(1'-Azacyclooctyl)ethylguanidine | ChEBI | | 2-(1-N,N-Heptamethyleneimino)ethylguanidine | ChEBI | | Guanethidinum | ChEBI | | Guanetidina | ChEBI | | N-(2-Perhydroazocin-1-ylethyl)guanidine | ChEBI | | Guanethidine monosulfate | HMDB | | Guanethidine monosulphate | HMDB | | Guanethidine sulphae | HMDB | | Guanethidine sulfate (1:1) | HMDB | | Guanethidine sulfate (2:1), 14C-labeled | HMDB | | Octadine | HMDB | | Oktadin | HMDB | | monoSulfate, guanethidine | HMDB | | Guanethidine sulfate | HMDB | | Guanethidine sulfate (1:2) | HMDB | | Guanethidine sulfate (2:1) | HMDB | | Ismelin | HMDB | | Isobarin | HMDB | | ((2-Hexahydro-1(2H)-azocinyl)ethyl)guanidine | HMDB | | Sulfate, guanethidine | HMDB |
|
|---|
| Chemical Formula | C10H22N4 |
|---|
| Average Molecular Weight | 198.3085 |
|---|
| Monoisotopic Molecular Weight | 198.184446724 |
|---|
| IUPAC Name | 2-[2-(azocan-1-yl)ethyl]guanidine |
|---|
| Traditional Name | ismelin |
|---|
| CAS Registry Number | 645-43-2 |
|---|
| SMILES | NC(N)=NCCN1CCCCCCC1 |
|---|
| InChI Identifier | InChI=1S/C10H22N4/c11-10(12)13-6-9-14-7-4-2-1-3-5-8-14/h1-9H2,(H4,11,12,13) |
|---|
| InChI Key | ACGDKVXYNVEAGU-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as guanidines. Guanidines are compounds containing a guanidine moiety, with the general structure (R1R2N)(R3R4N)C=N-R5. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic nitrogen compounds |
|---|
| Class | Organonitrogen compounds |
|---|
| Sub Class | Guanidines |
|---|
| Direct Parent | Guanidines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Tertiary aliphatic amine
- Tertiary amine
- Guanidine
- Azacycle
- Organoheterocyclic compound
- Carboximidamide
- Organopnictogen compound
- Hydrocarbon derivative
- Imine
- Amine
- Aliphatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aliphatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 250 °C (sulfate salt) | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 2.25 g/L | Not Available | | LogP | 0.8 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.05 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 8.8131 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.76 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 407.0 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 376.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 236.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 77.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 170.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 80.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 288.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 261.6 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 1016.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 608.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 41.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 505.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 147.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 220.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 1117.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 755.5 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 327.2 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Guanethidine,1TMS,isomer #1 | C[Si](C)(C)NC(N)=NCCN1CCCCCCC1 | 2056.5 | Semi standard non polar | 33892256 | | Guanethidine,1TMS,isomer #1 | C[Si](C)(C)NC(N)=NCCN1CCCCCCC1 | 1849.1 | Standard non polar | 33892256 | | Guanethidine,1TMS,isomer #1 | C[Si](C)(C)NC(N)=NCCN1CCCCCCC1 | 3375.7 | Standard polar | 33892256 | | Guanethidine,2TMS,isomer #1 | C[Si](C)(C)NC(=NCCN1CCCCCCC1)N[Si](C)(C)C | 2184.8 | Semi standard non polar | 33892256 | | Guanethidine,2TMS,isomer #1 | C[Si](C)(C)NC(=NCCN1CCCCCCC1)N[Si](C)(C)C | 1924.0 | Standard non polar | 33892256 | | Guanethidine,2TMS,isomer #1 | C[Si](C)(C)NC(=NCCN1CCCCCCC1)N[Si](C)(C)C | 3422.7 | Standard polar | 33892256 | | Guanethidine,2TMS,isomer #2 | C[Si](C)(C)N(C(N)=NCCN1CCCCCCC1)[Si](C)(C)C | 2126.8 | Semi standard non polar | 33892256 | | Guanethidine,2TMS,isomer #2 | C[Si](C)(C)N(C(N)=NCCN1CCCCCCC1)[Si](C)(C)C | 2034.6 | Standard non polar | 33892256 | | Guanethidine,2TMS,isomer #2 | C[Si](C)(C)N(C(N)=NCCN1CCCCCCC1)[Si](C)(C)C | 3393.8 | Standard polar | 33892256 | | Guanethidine,3TMS,isomer #1 | C[Si](C)(C)NC(=NCCN1CCCCCCC1)N([Si](C)(C)C)[Si](C)(C)C | 2181.3 | Semi standard non polar | 33892256 | | Guanethidine,3TMS,isomer #1 | C[Si](C)(C)NC(=NCCN1CCCCCCC1)N([Si](C)(C)C)[Si](C)(C)C | 2123.3 | Standard non polar | 33892256 | | Guanethidine,3TMS,isomer #1 | C[Si](C)(C)NC(=NCCN1CCCCCCC1)N([Si](C)(C)C)[Si](C)(C)C | 3171.5 | Standard polar | 33892256 | | Guanethidine,4TMS,isomer #1 | C[Si](C)(C)N(C(=NCCN1CCCCCCC1)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2256.9 | Semi standard non polar | 33892256 | | Guanethidine,4TMS,isomer #1 | C[Si](C)(C)N(C(=NCCN1CCCCCCC1)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2298.5 | Standard non polar | 33892256 | | Guanethidine,4TMS,isomer #1 | C[Si](C)(C)N(C(=NCCN1CCCCCCC1)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2837.1 | Standard polar | 33892256 | | Guanethidine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(N)=NCCN1CCCCCCC1 | 2245.8 | Semi standard non polar | 33892256 | | Guanethidine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(N)=NCCN1CCCCCCC1 | 2051.8 | Standard non polar | 33892256 | | Guanethidine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(N)=NCCN1CCCCCCC1 | 3538.6 | Standard polar | 33892256 | | Guanethidine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=NCCN1CCCCCCC1)N[Si](C)(C)C(C)(C)C | 2568.1 | Semi standard non polar | 33892256 | | Guanethidine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=NCCN1CCCCCCC1)N[Si](C)(C)C(C)(C)C | 2351.6 | Standard non polar | 33892256 | | Guanethidine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=NCCN1CCCCCCC1)N[Si](C)(C)C(C)(C)C | 3462.3 | Standard polar | 33892256 | | Guanethidine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C(N)=NCCN1CCCCCCC1)[Si](C)(C)C(C)(C)C | 2491.7 | Semi standard non polar | 33892256 | | Guanethidine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C(N)=NCCN1CCCCCCC1)[Si](C)(C)C(C)(C)C | 2433.3 | Standard non polar | 33892256 | | Guanethidine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C(N)=NCCN1CCCCCCC1)[Si](C)(C)C(C)(C)C | 3567.9 | Standard polar | 33892256 | | Guanethidine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=NCCN1CCCCCCC1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2765.8 | Semi standard non polar | 33892256 | | Guanethidine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=NCCN1CCCCCCC1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2730.3 | Standard non polar | 33892256 | | Guanethidine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=NCCN1CCCCCCC1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3231.1 | Standard polar | 33892256 | | Guanethidine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=NCCN1CCCCCCC1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3046.5 | Semi standard non polar | 33892256 | | Guanethidine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=NCCN1CCCCCCC1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3049.6 | Standard non polar | 33892256 | | Guanethidine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=NCCN1CCCCCCC1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3035.0 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Guanethidine GC-MS (Non-derivatized) - 70eV, Positive | splash10-05dl-9800000000-92577f077502658eda15 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Guanethidine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Guanethidine LC-ESI-QQ , positive-QTOF | splash10-0002-0900000000-63bf143534cccc53e099 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Guanethidine LC-ESI-QQ , positive-QTOF | splash10-000g-3900000000-b0c1213301460e6159e2 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Guanethidine LC-ESI-QQ , positive-QTOF | splash10-000f-8900000000-a1d8b2ab68936ac02c48 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Guanethidine LC-ESI-QQ , positive-QTOF | splash10-007c-9200000000-091425f6c0c880a5afdd | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Guanethidine LC-ESI-QQ , positive-QTOF | splash10-0a4r-9000000000-3d40142c51842fbbf5fc | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanethidine 10V, Positive-QTOF | splash10-0002-2900000000-3c0d9ad535e10192de33 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanethidine 20V, Positive-QTOF | splash10-01pc-9800000000-f1d0a92cd4e7f5d5da78 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanethidine 40V, Positive-QTOF | splash10-03di-9200000000-7f351fa76ffff520f407 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanethidine 10V, Negative-QTOF | splash10-0a4j-2900000000-85cc5b54f54b4d66b7d7 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanethidine 20V, Negative-QTOF | splash10-0a4i-2900000000-5456c549767554136a2a | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanethidine 40V, Negative-QTOF | splash10-052f-9100000000-72d038e0b4bab6976722 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanethidine 10V, Positive-QTOF | splash10-0002-0900000000-ef3ffa4801d71aa44093 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanethidine 20V, Positive-QTOF | splash10-0006-2900000000-71e448522ec8b2788ede | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanethidine 40V, Positive-QTOF | splash10-03dl-6900000000-7f013e5325db2e146174 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanethidine 10V, Negative-QTOF | splash10-0udj-0900000000-364208ae432e6172afa5 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanethidine 20V, Negative-QTOF | splash10-0udi-0900000000-661b5d94a8a02cdcfc2a | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Guanethidine 40V, Negative-QTOF | splash10-006x-4900000000-936412e2b075cbd2a91e | 2021-10-11 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum |
IR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
|---|